Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1233 to 1282 of 3228 in total
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.16666666666667\textwidth} \def\wcB{0.16666666666667\textwidth} \def\wcC{0.16666666666667\textwidth} \def\wcD{0.16666666666667\textwidth} \def\wcE{0.16666666666667\textwidth} \begin{longtable}{|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 1233\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent tyrosinase precursor (ec 1.14.18.1) (monophenol monooxygenase) (tumor rejection antigen ab) (sk29-ab) (lb24-ab). [source:swissprot;acc:p14679]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6004.54\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6514.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.08489\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1234\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent similar to ecotropic viral integration site 5; neuroblastoma stage 4s gene. [source:refseq;acc:nm\_145245]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5807.83\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6300.47\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.08482\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1235\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ecotropic viral integration site 5; neuroblastoma stage 4s gene. [source:refseq;acc:nm\_005665]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1236\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent p10-binding protein. [source:refseq;acc:nm\_024491]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5594.18\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6067.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.08461\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1237\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent tsc22-related inducible leucine zipper protein 2 (tsc-22-like protein thg-1). [source:swissprot;acc:q9y3q8]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5873.56\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6370.31\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.08457\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1238\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sphingolipid delta 4 desaturase; membrane fatty acid (lipid) desaturase; dihydroceramide desaturase. [source:refseq;acc:nm\_003676]\vspace{3pt}}&&&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1239\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent daz associated protein 1 isoform b; deleted in azoospermia associated protein 1. [source:refseq;acc:nm\_018959]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5654.53\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6132.76\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1240\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent retinoic acid induced 17; pias-like protein hzimp10. [source:refseq;acc:nm\_020338]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5654.54\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6132.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.08456\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1241\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 26s proteasome non-atpase regulatory subunit 2 (26s proteasome regulatory subunit s2) (26s proteasome subunit p97) (tumor necrosis factor type 1 receptor associated protein 2) (55.11 protein). [source:swissprot;acc:q13200]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6436.19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6980.13\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.08451\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1242\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ubiquitin-conjugating enzyme e2 e1 (ec 6.3.2.19) (ubiquitin-protein ligase e1) (ubiquitin carrier protein e1) (ubch6). [source:swissprot;acc:p51965]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 11143.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 10276.3\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.08439\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1243\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ubiquitin-conjugating enzyme e2e 3; ubiquitin carrier protein; ubiquitin-protein ligase. [source:refseq;acc:nm\_006357]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1244\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sirtuin 7; sir2-related protein type 7; sirtuin type 7; sirtuin (silent mating type information regulation 2, s.cerevisiae, homolog) 7; silent mating type information regulation 2, s.cerevisiae, homolog 7; sirtuin silent mating type information regulation 2 homolog 7 (s. cerevisiae). [source:refseq;acc:nm\_016538]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 4835.55\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5243.23\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.08431\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1245\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent casein kinase ii beta chain (ck ii) (phosvitin) (g5a). [source:swissprot;acc:p13862]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1246\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent p53-related protein kinase (ec 2.7.1.-) (nori-2). [source:swissprot;acc:q96s44]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5346.11\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5796.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.08429\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1247\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent protein-tyrosine phosphatase, non-receptor type 1 (ec 3.1.3.48) (protein-tyrosine phosphatase 1b) (ptp-1b). [source:swissprot;acc:p18031]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6278.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6807.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.08421\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1248\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent protein-tyrosine phosphatase, non-receptor type 2 (ec 3.1.3.48) (t- cell protein-tyrosine phosphatase) (tcptp). [source:swissprot;acc:p17706]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6275.86\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6803.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.08415\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1249\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent trans-prenyltransferase; polyprenyl pyrophosphate synthetase. [source:refseq;acc:nm\_014317]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4413.55\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4784.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.08407\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1250\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent huntingtin interacting protein 1 (hip-i). [source:swissprot;acc:o00291]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 10733.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 9902.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.0839\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1251\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent regulator of chromosome condensation (cell cycle regulatory protein). [source:swissprot;acc:p18754]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 8618.32\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 9340.98\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.08385\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1252\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent zinc finger homeobox protein 1b (smad interacting protein 1) (smadip1) (hrihfb2411). [source:swissprot;acc:o60315]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1253\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent transcription factor 8 (nil-2-a zinc finger protein) (negative regulator of il2). [source:swissprot;acc:p37275]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1254\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent goodpasture antigen-binding protein (ec 2.7.1.37) (gpbp) (collagen type iv alpha 3 binding protein) (star-related lipid transfer protein 11) (stard11) (start domain-containing protein 11). [source:swissprot;acc:q9y5p4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 10725.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 9896.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.0838\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1255\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent serine/threonine protein phosphatase 4 (ec 3.1.3.16) (pp4) (protein phosphatase x) (pp-x). [source:swissprot;acc:p33172]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5438.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5893.87\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.0837\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1256\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent huntingtin interacting protein 1 related (hip1-related) (hip 12). [source:swissprot;acc:o75146]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 10719\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 9891.08\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1257\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent immunoglobulin-binding protein 1 (cd79a-binding protein 1) (b cell signal transduction molecule alpha 4) (alpha 4 protein). [source:swissprot;acc:p78318]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5438.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5893.87\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1258\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent glutamate carboxypeptidase-like protein 2 precursor. [source:swissprot;acc:q96kn2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6251.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6774.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.08363\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1259\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent epidermal growth factor receptor pathway substrate 8-like protein 1 isoform c; epidermal growth factor receptor pathway substrate 8-related protein 1; eps8-related protein 1. [source:refseq;acc:nm\_139204]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5685.38\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6157.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.08308\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1260\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent rad54-like protein; rad54 homolog. [source:refseq;acc:nm\_003579]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5754.84\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6232.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.08306\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1261\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent epidermal growth factor receptor kinase substrate eps8. [source:swissprot;acc:q12929]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5685.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6157.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.08305\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1262\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent serine/threonine protein kinase 23 (ec 2.7.1.37) (muscle-specific serine kinase 1) (mssk-1). [source:swissprot;acc:q9upe1]\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5894.47\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6383.73\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.083\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1263\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent gtp binding protein 2. [source:refseq;acc:nm\_019096]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1264\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cyclic-amp-dependent transcription factor atf-6 beta (activating transcription factor 6 beta) (atf6-beta) (camp responsive element binding protein-like 1) (camp response element binding protein-related protein) (creb-rp) (g13 protein). [source:swissprot;acc:q99941]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1265\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dna segment on chromosome 6(unique) 2654 expressed sequence; dna segment on chromosome x (unique) 2654 expressed sequence. [source:refseq;acc:nm\_012135]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1266\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sfrs protein kinase 2 isoform b. [source:refseq;acc:nm\_182691]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1267\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cyclic-amp-dependent transcription factor atf-6 alpha (activating transcription factor 6 alpha) (atf6-alpha). [source:swissprot;acc:p18850]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1268\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sfrs protein kinase 1; sr protein kinase 1. [source:refseq;acc:nm\_003137]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1269\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent xap-5 protein (hxc-26 protein). [source:swissprot;acc:q14320]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1270\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent epidermal growth factor receptor pathway substrate 8-like protein 2; eps8-related protein 2; epidermal growth factor receptor pathway substrate 8-related protein 2. [source:refseq;acc:nm\_022772]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5685.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6156.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.08292\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1271\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent mitotic checkpoint serine/threonine-protein kinase bub1 beta (ec 2.7.1.-) (hbubr1) (mad3/bub1-related protein kinase) (mitotic checkpoint kinase mad3l). [source:swissprot;acc:o60566]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5528.65\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5985.58\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.08265\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1272\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent pyridoxine 5'-phosphate oxidase. [source:refseq;acc:nm\_018129]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1273\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent phafin 2; ph and fyve domain-containing protein 2. [source:refseq;acc:nm\_024613]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5885\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6371.14\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.08261\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1274\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 3-oxo-5-alpha-steroid 4-dehydrogenase 1 (ec 1.3.99.5) (steroid 5-alpha-reductase 1) (sr type 1) (s5ar). [source:swissprot;acc:p18405]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1275\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 3-oxo-5-alpha-steroid 4-dehydrogenase 2 (ec 1.3.99.5) (steroid 5-alpha-reductase 2) (sr type 2) (5 alpha-sr2). [source:swissprot;acc:p31213]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1276\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent peroxisomal membrane protein 2 (22 kda peroxisomal membrane protein). [source:swissprot;acc:q9nr77]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 6437.99\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6969.67\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.08258\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1277\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent heat shock-related 70 kda protein 2 (heat shock 70 kda protein 2). [source:swissprot;acc:p54652]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1278\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent heat shock 70 kda protein 1 (hsp70.1) (hsp70-1/hsp70-2). [source:swissprot;acc:p08107]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1279\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent heat shock cognate 71 kda protein. [source:swissprot;acc:p11142]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1280\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dehydrodolichyl diphosphate synthase. [source:refseq;acc:nm\_024887]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6350.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6874.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.08252\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1281\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent orphan nuclear receptor hmr (early response protein nak1) (tr3 orphan receptor). [source:swissprot;acc:p22736]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6230.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6744.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.0825\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1282\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nuclear hormone receptor nor-1 (neuron-derived orphan receptor 1) (mitogen induced nuclear orphan receptor). [source:swissprot;acc:q92570]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6230.38\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6744.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.08249\vspace{3pt}}\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/